Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa

Domain:

healthcare
Creator:
M.AF. O.OT.
Publisher:
Fro
Host:
Ganoderma lucidum is a well-known medicinal mushroom that has been used for the prevention and treatment of different ailments to enhance longevity and health specifically in China, Japan, and Korea. It was known as “God’s herb” in ancient China as it was believed to prolong life, enhance the youthful spirit and sustain/preserve vitality. G. lucidum is seldom collected from nature and is substantially cultivated on wood logs and sawdust in plastic bags or bottles to meet the international market demand. Both in vitro and in vivo studies on the copious metabolic activities of G. lucidum have been carried out. Varied groups of chemical compounds including triterpenoids, polysaccharides, proteins, amino acids, nucleosides, alkaloids, steroids, lactones, lectins, fatty acids, and enzymes with potent pharmacological activities have been isolated from the mycelia and fruiting bodies of G. lucidum. Several researchers have reported the abundance and diversification of its biological actions triggered by these chemical compounds. Triterpenoids and polysaccharides of G. lucidum have been reported to possess cytotoxic, hepatoprotective, antihypertensive, hypocholesterolemic, antihistaminic effects, antioxidant, antimicrobial, anti-inflammatory, hypoglycemic antiallergic, neuroprotective, antitumor, immunomodulatory and antiangiogenic activities. Various formulations have been developed, patented, and utilized as nutraceuticals, cosmeceuticals, and pharmaceuticals from G. lucidum extracts and active compounds. Thus, this review presents current updates on emerging infectious diseases and highlights the scope, dynamics, and advances in infectious disease management with a particular focus on Ganoderma lucidum, an unutilized natural medicine as a promising future solution to emerging diseases in Africa. However, details such as the chemical compound and mode of action of each bioactive against different emerging diseases were not discussed in this study.

Visit

doi.org

Licenses

https://creativecommons.org/licenses/by/4.0/

Similar

Morphological characters and phylogenetic analysis reveal a new species within the Ganoderma lucidum complex from South AfricaAnti-trypanosomal, antioxidant and antimicrobial activities of the fruiting bodies of Ganoderma lucidum (W. Curt.: Fr) (Ganodermataceae) aqueous extractTheorizing an equitable and promising future for scientific progress in Africa: a bioethical and human rights-based approach to clinical trials Theorizing an equitable and promising future for scientific progress in Africa: a bioethical and human rights-based approach to clinical trialsIsolation of Ganoderma lucidum (Curtis) P. Karst. From the Wild in Lagos through Tissue Culture Techniques and Cultivation on Sawdust of Six Nigerian HardwoodsThe future of genomic medicine education in AfricaImpact of Climate Change on Animal Health, Emerging and Re-emerging Diseases in Africa

Morphological characters and phylogenetic analysis reveal a new species within the Ganoderma lucidum complex from South Africa

Xing, Jia-Hui, Song, Jie, Decock, Cony, Cui, Bao-Kai (2016): Morphological characters and phylogenet

Anti-trypanosomal, antioxidant and antimicrobial activities of the fruiting bodies of Ganoderma lucidum (W. Curt.: Fr) (Ganodermataceae) aqueous extract

Human African Trypanosomiasis (HAT) infection is caused by sub species of Trypanosoma brucei. The cl

Theorizing an equitable and promising future for scientific progress in Africa: a bioethical and human rights-based approach to clinical trials Theorizing an equitable and promising future for scientific progress in Africa: a bioethical and human rights-based approach to clinical trials

This study focuses on clinical trials in Africa and suggests that a human rights-based and biolegal

Isolation of Ganoderma lucidum (Curtis) P. Karst. From the Wild in Lagos through Tissue Culture Techniques and Cultivation on Sawdust of Six Nigerian Hardwoods

Cultivation of Ganoderma lucidum (Curtis) P. Karst, a medicinal mushroom known

The future of genomic medicine education in Africa

Abstract There are many challenges and opportunities for Africans in the emergin

Impact of Climate Change on Animal Health, Emerging and Re-emerging Diseases in Africa

Abstract The threat of climate change and global warming is gaining worldwide recognition. The Afri